Eleanor J. Cheadle
- Oncology top 1%
- Immunology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Biomedical Engineering top 10%
- Co-authors
- Tim IllidgeJamie HoneychurchSimon J. DovediRobert W. WilkinsonDavid E. GilhamRoss StewartMichelle MorrowEdmund Poon
- Topics
- Immunotherapy and Immune Responses (20 papers)CAR-T cell therapy research (19 papers)Immune Cell Function and Interaction (9 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Eleanor J. Cheadle
35 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 2.1k
- Immunology 1.2k
- Pulmonary and Respiratory Medicine 494
- Molecular Biology 439
- Biomedical Engineering 369
Countries citing papers authored by Eleanor J. Cheadle
This map shows the geographic impact of Eleanor J. Cheadle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor J. Cheadle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor J. Cheadle more than expected).
Fields of papers citing papers by Eleanor J. Cheadle
This network shows the impact of papers produced by Eleanor J. Cheadle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor J. Cheadle. The network helps show where Eleanor J. Cheadle may publish in the future.
Co-authorship network of co-authors of Eleanor J. Cheadle
This figure shows the co-authorship network connecting the top 25 collaborators of Eleanor J. Cheadle. A scholar is included among the top collaborators of Eleanor J. Cheadle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleanor J. Cheadle. Eleanor J. Cheadle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 11 | |
| 3 | 16 | |
| 4 | 68 | |
| 5 | 93 | |
| 6 | 18 | |
| 7 | 263 | |
| 8 | 44 | |
| 9 | Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockadebreakdown → | 974 |
| 10 | 17 | |
| 11 | 36 | |
| 12 | 222 | |
| 13 | 61 | |
| 14 | 26 | |
| 15 | 1 | |
| 16 | 2 | |
| 17 | 17 | |
| 18 | 255 | |
| 19 | 18 | |
| 20 | 64 |
About Eleanor J. Cheadle
Eleanor J. Cheadle is a scholar working on Immunology, Oncology and Genetics, having authored 35 papers that have together received 2.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (20 papers), CAR-T cell therapy research (19 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Oncology (2.1k citations), Immunology (1.2k citations) and Genetics (243 citations). Eleanor J. Cheadle has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Tim Illidge, Jamie Honeychurch, Simon J. Dovedi, Robert W. Wilkinson, David E. Gilham, Ross Stewart, Michelle Morrow, Edmund Poon, Robert E. Hawkins and Grazyna Lipowska‐Bhalla. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.